Tick saliva is thought to contain a number of molecules that prevent host immune and inflammatory responses. In this study, the effects of Ixodes scapularis saliva on cytokine production by bone marrow-derived dendritic cells (DCs) from C57BL/6 mice stimulated by TLR-2, TLR-4, and TLR-9 ligands were studied. Saliva at remarkably diluted concentrations (<1/2000) promotes a dose-dependent inhibition of IL-12 and TNF-α production induced by all TLR ligands used. Using a combination of fractionation techniques (microcon filtration, molecular sieving, and reversed-phase chromatography), we unambiguously identified PGE2 as the salivary inhibitor of IL-12 and TNF-α production by DCs. Moreover, we have found that I. scapularis saliva (dilution 1/200; ∼10 nM PGE2) marginally inhibited LPS-induced CD40, but not CD80, CD86, or MHC class II expression. In addition, saliva significantly suppressed the ability of DCs to stimulate Ag-specific CD4+ T cell proliferation and IL-2 production. Notably, the effect of saliva on DC maturation and function was reproduced by comparable concentrations of standard PGE2. These findings indicate that PGE2 accounts for most inhibition of DC function observed with saliva in vitro. The role of salivary PGE2 in vector-host interaction and host immune modulation and inflammation in vivo is also discussed. This study is the first to identify molecularly a DC inhibitor from blood-sucking arthropods.

Dendritic cells (DCs)5 are professional APCs that initiate the adaptive immune response to invading pathogens, and are found in two distinct functional states. Immature DCs are located in nonlymphoid tissues, such as skin and mucosa, and their primary function is to uptake Ags. In contrast, mature DCs are poorly phagocytic, but highly efficient stimulators of naive T cell responses (1). Accordingly, DCs produce IL-12 and TNF-α during the maturation process. These cytokines are involved in inflammation and differentiation of Th1 cells, as well as in the up-regulation of costimulatory molecules, including CD40, CD80, and CD86 (2, 3). DCs are probably one of the first immune defense cells activated by tick-transmitted pathogens during blood feeding. Failure to fully activate DCs may result in an unbalanced immune response, and consequently, in increased infection by tick-borne diseases.

In their adaptation to hematophagy, blood-sucking arthropods evolved salivary components that prevent their rejection and potentially enhance pathogen transmission. This is particularly true for hard ticks that remain attached to their hosts for several consecutive days (4). Therefore, ticks must modulate host inflammatory, immune, and vascular systems to successfully feed on blood and complete their life cycle. Several molecules have been described in tick saliva, including anticoagulants (5, 6), as well as vasodilator (7) and angiogenesis inhibitors (8). Immunomodulators (9, 10) such as inhibitors of neutrophil (11, 12) and T lymphocyte function (13, 14) in addition to an IL-2-binding protein (15) have been reported. Furthermore, in vivo and in vitro inhibition of cytokines has been demonstrated by Ixodes scapularis and other species of hard ticks. For example, macrophage production of IL-1 and TNF-α, as well as lymphocyte production of IL-2 and IFN-γ, were diminished in the presence of Dermacentor andersoni salivary gland extracts (16). In addition, splenocytes from C3H/HeJ mice infested with I. scapularis nymphs presented decreased production of IL-2 and IFN-γ and increased production of IL-4 and IL-10 when stimulated with Con A (17, 18). Also, saliva of Rhipicephalus sanguineus inhibited Con A-induced IL-2 production by splenocytes (19) and IL-12 production by LPS-stimulated bone marrow-derived DCs (20). Despite the potentially critical role of these molecules in the biology of tick feeding and host-vector interaction, their molecular identification has remained elusive to date.

In this study, we have identified for the first time PGE2 isolated directly from tick saliva as the main inhibitor of inflammatory and Th1-related cytokine production and of T cell stimulation by murine DCs. Remarkably, concentration-response assays performed using I. scapularis saliva and a commercial standard indicate that the amount of PGE2 in saliva accounts for most of its immunosuppressive effects on DC maturation and function observed in vitro.

Six- to 10-wk-old female C57BL/6 mice and DO11.10 mice that express transgenic TCR specific for OVA peptide 323–339 were purchased from Taconic Farms. Animals were bred and maintained at an American Association of Laboratory Animal Care-accredited facility at the National Institute of Allergy and Infectious Diseases, National Institutes of Health.

I. scapularis saliva was obtained by inducing partially engorged adult female I. scapularis to salivate (3–4 days postattachment to a rabbit) into capillary tubes using the modified pilocarpine induction method (21).

Ultrapure Escherichia coli 0111:B4 LPS, peptidoglycan (PGN), and oligonucleotide CpG (1826) were purchased from InvivoGen.

DCs were generated according to the method of Inaba et al. (22) with modifications (23). Briefly, bone marrow cells from the femurs of C57BL/6 mice were cultured in complete medium (RPMI 1640 medium with 10% heat-inactivated FBS, 2 mM l-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 0.05 mM 2-ME) and 20 ng/ml murine rGM-CSF (Sigma-Aldrich). At day 0, cells were seeded at 106 per 100-mm petri dish (Falcon 1029 plates; BD Discovery Labware) in 10 ml of medium. At days 3 and 6, another 10 ml of complete medium containing 20 ng/ml murine rGM-CSF was added to the plates. In a setting of experiments, CD11c+ cells (enriched DCs) were obtained, as described elsewhere (24). In brief, DC suspensions were incubated with anti-CD11c MicroBeads (Miltenyi Biotec) for 15 min at 4°C, followed by a washing step in PBS/BSA, and then sorted using MACS columns (LS). Analysis of the sorted cells showed purity 80–90% CD11c+ cells (data not shown).

Six- to 9-day cultured bone marrow-derived DCs were gently collected, washed twice, and resuspended at 106 cells/ml in complete medium. Cells were cultured at 105 cells/well in round-bottom 96-well cluster plates (Costar, Corning Glass) and incubated with medium, saliva, saliva fractions, or PGE2 for 30 min before the addition of TLR2 (PGN, 10 μg/ml), TLR4 (LPS, 100 ng/ml), or TLR9 (CpG ODN 1826, 0.15 μM) ligands. Following overnight incubation at 37°C and 5% of CO2, cell-free supernatants were collected and diluted accordingly to the IL-12p40, IL-12p70, TNF-α, and IL-10 determination by using BD OptEIA ELISA sets, according to manufacturer’s instructions (BD Biosciences). In some experiments, LPS-stimulated CD11c+ cells were used for cytokine production assay, as described above.

Molecular sieving HPLC of saliva was performed using a Superdex 75 column (3.2 × 300 mm) (Amersham Biosciences), and eluted at 0.05 ml/min with 10 mM HEPES buffer (pH 7.2), containing 0.15 M NaCl. The solvent was delivered using a CM-4100 pump (ThermoSeparation Products). The eluent was monitored for UV absorbance at 220 nm (SM-4100 UV Spectrophotometer; ThermoSeparation Products) with fractions being collected at 1-min intervals using a FC203-B fraction collector (Gilson). The activity of each fraction on LPS-induced IL-12p40 and TNF-α production was tested. The column was calibrated using BSA, OVA, carbonic anhydrase, myoglobin, cytochrome c, angiotensin 1, tyrosine, and tryptophan.

Reversed-phase HPLC of Microcon YM-3 (Millipore) filtered saliva was performed on a C18 column (0.5 × 150 mm; ThermoSeparation Products) perfused at 25 μl/min using a PerkinElmer ABI 1400 pump. The eluent was monitored at 220 nm using a 785A detector (PerkinElmer). A gradient of 60-min duration from 5 to 90% acetonitrile in water, containing 0.1% trifluoroacetic acid, was imposed after injecting of the sample. Aliquots of these fractions were tested for cytokine-inhibitory activity. Sample loops of 20 or 100 μl were used.

Nanoflow reversed-phase liquid chromatography (RPLC) analyses were performed using an Agilent 1100 nano liquid chromatography system (Agilent) coupled online to a linear ion trap-Fourier transform ion cyclotron resonance mass spectrometer (LTQ-FTICR; Thermo Electron) using nanoelectrospray ionization. Separations were performed using 75-μm internal diameter × 360-μm outer diameter × 10-cm-long fused silica capillary columns (Polymicro Technologies) that were slurry packed in-house with 5-μm, 300 Å pore size C-18 silica-bonded stationary phase (Phenomenex). After injecting 6 μl of sample, the column was washed for 20 min with 98% mobile phase A (0.1% formic acid in water) at a flow rate of 500 nL/min. A linear gradient of 2% mobile phase B (0.1% formic acid in acetonitrile) to 90% mobile phase B in 25 min, then to 98% B in an additional 25 min, all at a constant flow rate of 200 nL/min, was used for all nanoLC-mass spectrometry (MS) analyses. The LTQ-FTICR was operated in a data-dependent tandem mass spectrometry (MS/MS) mode in which each full high resolution LTQ-FTICR scan is followed by five MS/MS scans in which the five most abundant molecular ions are dynamically selected for collision-induced dissociation using a normalized collision energy of 35%. Dynamic exclusion was used to minimize redundant acquisition of molecules previously selected for collision-induced dissociation. The heated capillary temperature and electrospray voltage were set at 160°C and 1.5 kV, respectively.

The amount of PGE2 in saliva samples as well as its concentration in the medium used for cell culture were determined by competition ELISA kit (R&D Systems), according to manufacturer’s instructions. The detection limit for the assay is 20 pg/ml.

Four million bone marrow-derived DCs were preincubated with medium, whole saliva, filtrate of Microcon YM-3, or different concentrations of PGE2. After 30 min, medium or LPS (100 ng/ml) was added and incubated overnight. The supernatant was collected for cytokine determination, and the cells were washed twice and stained with fluorochrome-labeled Abs against CD11c, CD40, CD80, CD86, and MHC class II (I-Ab; BD Pharmingen). A total of 100,000 live cell events as gated on forward and side scatter characteristics were acquired. Data were collected using a FACSCalibur (BD Immunocytometry Systems) with CellQuest (BD Biosciences) and analyzed with FlowJo software (Tree Star).

Bone marrow-derived DCs were preincubated with medium, whole saliva, filtrate of Microcon YM-3, or different concentrations of PGE2. After 30 min, medium and OVA (100 μg/ml) were added in the presence of LPS (100 ng/ml) and incubated overnight. After three washings, 25,000 cells were cocultured for 72 h in the presence of 100,000 CD4+ T cells purified from spleens of congenic DO11.10 mice using Mouse CD4 Negative Isolation Kit (Dynal Biotech). Alamar Blue (Trek Diagnostic Systems) was added at 10% of incubation volume in the last 48 h of the culture. The cell proliferation was evaluated by reading the culture absorbance at 570 and 600 nm, as previously described (25).

Data are shown as mean ± SEM. Statistical differences were analyzed by ANOVA. A p value of 0.05 or less was considered statistically significant.

Following treatment with purified TLR agonists PGN (TLR2), LPS (TLR4), or CpG (TLR9), DCs produced high levels of both IL-12p40 and TNF-α (Fig. 1). When cultures were preincubated with saliva for 30 min at 1/200 dilution, significant inhibition of LPS- or PGN-induced IL-12p40 production by DCs was observed, whereas CPG-induced IL-12p40 production was only marginally inhibited (Fig. 1, A–C). At 1/667 dilution, saliva only significantly inhibited IL-12p40 production induced by LPS, but no significant effect on CPG- or PGN-induced IL-12p40 synthesis was observed at this or higher dilutions (Fig. 1, A–C). In addition, saliva diluted at 1/200, 1/667, and 1/2000 strongly inhibited TLR ligand-induced TNF-α production by these cells. For example, saliva at 1/6667 dilutions produced 50% reduction in TNF-α levels induced by all three ligands (p < 0.001; Fig. 1, D–F). Cell death was not detected in cultures incubated with TLR ligands in the presence of saliva or medium (data not shown), and basal levels of IL-12p40 and TNF-α were not changed in cultures incubated with saliva only (data not shown).

FIGURE 1.

I. scapularis saliva inhibits IL-12p40 (A–C) and TNF-α (DF) production by bone marrow-derived DCs stimulated by TLR ligands in a dose-dependent manner. DCs from C57BL/6 mice were generated by incubation with GM-CSF for 6–9 days. Then, cells were washed twice and preincubated with medium or different saliva dilutions. After 30 min, cells were stimulated overnight with TLR-4 (LPS, 100 ng/ml; A and D), TLR-2 (PGN, 10 μg/ml; B and E), or TLR-9 (CPG, 150 nM; C and F) ligands. Cytokine levels in culture supernatants were measured by ELISA. ∗, p < 0.05 vs LPS, CPG, and PGN groups without saliva dilutions.

FIGURE 1.

I. scapularis saliva inhibits IL-12p40 (A–C) and TNF-α (DF) production by bone marrow-derived DCs stimulated by TLR ligands in a dose-dependent manner. DCs from C57BL/6 mice were generated by incubation with GM-CSF for 6–9 days. Then, cells were washed twice and preincubated with medium or different saliva dilutions. After 30 min, cells were stimulated overnight with TLR-4 (LPS, 100 ng/ml; A and D), TLR-2 (PGN, 10 μg/ml; B and E), or TLR-9 (CPG, 150 nM; C and F) ligands. Cytokine levels in culture supernatants were measured by ELISA. ∗, p < 0.05 vs LPS, CPG, and PGN groups without saliva dilutions.

Close modal

Because IL-12p40 is a subunit shared by both IL-12 and IL-23 (26), we investigated whether saliva from I. scapularis influenced synthesis of IL-12p70 production, the bioactive IL-12. Fig. 2,A shows that stimulation of DCs by LPS is accompanied by IL-12p70 production, which was completely inhibited by saliva at 1/200 dilutions (p < 0.001). Strong inhibition was also observed at dilutions of 1/667, 1/2000, and 1/6667 (98.6, 89.4, and 69.7% inhibition, respectively). Stimulation of DCs by LPS was also accompanied by production of IL-23, which was not diminished by saliva (data not shown). Anti-inflammatory cytokines such as IL-10 are also induced by LPS (27), and it may be regulated by I. scapularis saliva. We next measured this mediator in LPS-stimulated DCs pretreated with saliva. As shown in Fig. 2 B, saliva at 1/200 and 1/667 dilutions significantly increases IL-10 production by DCs, reaching levels 2- to 3-fold higher than detected with LPS alone.

FIGURE 2.

I. scapularis saliva inhibits LPS-induced IL-12p70 (A) and stimulates IL-10 (B) production by bone marrow-derived DCs in a dose-dependent manner. DCs from C57BL/6 mice were generated by incubation with GM-CSF for 6–9 days. Then, cells were washed twice and preincubated with medium or different saliva dilutions. After 30 min, cells were stimulated overnight with LPS (100 ng/ml). Cytokine levels in culture supernatants were measured by ELISA. ∗, p < 0.05 vs LPS group without saliva dilutions.

FIGURE 2.

I. scapularis saliva inhibits LPS-induced IL-12p70 (A) and stimulates IL-10 (B) production by bone marrow-derived DCs in a dose-dependent manner. DCs from C57BL/6 mice were generated by incubation with GM-CSF for 6–9 days. Then, cells were washed twice and preincubated with medium or different saliva dilutions. After 30 min, cells were stimulated overnight with LPS (100 ng/ml). Cytokine levels in culture supernatants were measured by ELISA. ∗, p < 0.05 vs LPS group without saliva dilutions.

Close modal

To identify molecule(s) responsible for the observed immunomodulatory effects, I. scapularis saliva was applied to a gel-filtration column and fractions were tested for inhibition of LPS-stimulated DCs. Fig. 3,A depicts the chromatogram of I. scapularis saliva, and Fig. 3, B and C, respectively, shows the inhibition of IL-12p40 and TNF-α synthesis by DCs observed within a fraction eluting with a retention time of 22 min. These results suggest that the apparent molecular mass of the active molecule(s) is smaller than 1000 Da (Fig. 3 A, inset). Because the pilocarpin (used for tick salivation) peak eluted at 34 min (∼210 Da), it did not contaminate the fraction containing the inhibitory activity.

FIGURE 3.

Inhibitor(s) of DC cytokine production eluted as a single peak with <1,000 Da. Molecular sieving chromatogram of whole saliva (A). Standard curve prepared with BSA (66,000 Da), OVA (44,287 Da), carbonic anhydrase (29,000 Da), myoglobin (18,800 kDa), cytochrome c (12,241 kDa), angiotensin 1 (1,296 Da), tyrosine (181 Da), and tryptophan (204 Da) (inset). Effect of each fraction on IL-12p40 (B) and TNF-α (C) production by LPS-stimulated DCs was determined by ELISA.

FIGURE 3.

Inhibitor(s) of DC cytokine production eluted as a single peak with <1,000 Da. Molecular sieving chromatogram of whole saliva (A). Standard curve prepared with BSA (66,000 Da), OVA (44,287 Da), carbonic anhydrase (29,000 Da), myoglobin (18,800 kDa), cytochrome c (12,241 kDa), angiotensin 1 (1,296 Da), tyrosine (181 Da), and tryptophan (204 Da) (inset). Effect of each fraction on IL-12p40 (B) and TNF-α (C) production by LPS-stimulated DCs was determined by ELISA.

Close modal

To identify the molecule(s) involved in the inhibition of IL-12p40 and TNF-α synthesis, a 50-μL aliquot of saliva was filtered using a Microcon YM3. The filtrate (representing molecules with mass <3000 Da) was resolved by reversed-phase HPLC (Fig. 4,A), and the activity of each fraction was tested on LPS-stimulated DCs (Fig. 4, B and C). Fraction 62, which eluted at the end of the gradient, produced the highest inhibition of both IL-12p40 (Fig. 4,B) and TNF-α (Fig. 4 C) production. The assay was repeated with fractions that induced stronger inhibition of these cytokines (OD ≤0.25 for IL-12p40 and OD ≤0.20 for TNF-α), and fraction 62 was consistently confirmed as the single active fraction (data not shown).

FIGURE 4.

Isolation of the DC modulator from I. scapularis saliva by RPLC. Fifty microliters of saliva was filtered using a YM-3 (cutoff 3,000 Da) membrane and fractionated by RPLC using the conditions described in Materials and Methods (A). Effect of each fraction on IL-12p40 (B) and TNF-α (C) production by LPS-stimulated DCs was determined by ELISA.

FIGURE 4.

Isolation of the DC modulator from I. scapularis saliva by RPLC. Fifty microliters of saliva was filtered using a YM-3 (cutoff 3,000 Da) membrane and fractionated by RPLC using the conditions described in Materials and Methods (A). Effect of each fraction on IL-12p40 (B) and TNF-α (C) production by LPS-stimulated DCs was determined by ELISA.

Close modal

Next, fraction 62 was analyzed by nano RPLC-MS, which revealed a single prominent peak at 31 min (Fig. 5,A). A series of molecular ions was observed in the mass spectrum at regular intervals of mass-to-charge (m/z) 352.22 (Fig. 5,B). The MS/MS spectra of the molecular ions shown in Fig. 4,B were largely uninformative, arising from poor fragmentation (Fig. 5 C). Comparison of the MS results with data contained within the METLIN Metabolite Database (http://metlin.scripps.edu/metabo_advanced.php) indicated that the molecular ion observed in these analyses was most likely PGE2 (C20H32O5). This result was subsequently validated using a PGE2-specific ELISA. The amount of PGE2 found by ELISA in a saliva sample was 505 ng/ml, representing a pharmacological concentration ∼1.43 μM PGE2.

FIGURE 5.

Identification of PGE2 in the positive inhibitory fraction. A, Base peak chromatogram of the predominant ion in the positive inhibitor fraction. B, Peaks observed from the molecular species eluting at 31.30 min, showing the consecutive loss of 352.22 Da. C, Tandem mass spectrometry spectra of the molecular ions shown in B (zoomed ×10 for detail).

FIGURE 5.

Identification of PGE2 in the positive inhibitory fraction. A, Base peak chromatogram of the predominant ion in the positive inhibitor fraction. B, Peaks observed from the molecular species eluting at 31.30 min, showing the consecutive loss of 352.22 Da. C, Tandem mass spectrometry spectra of the molecular ions shown in B (zoomed ×10 for detail).

Close modal

In an attempt to determine the relative contribution of salivary PGE2 in the inhibition of IL-12p40 and TNF-α production by DCs, concentration-response curves were performed using a standard commercial PGE2 and compared with the inhibition attained with given dilutions of saliva or YM-3 filtrate. An aliquot was taken from all these samples and used for estimation of PGE2 concentration by ELISA. In these experiments, DC preparation was enriched with CD11c+ to rule out the contribution of macrophages or neutrophils in cytokine production. Fig. 6 shows the inhibitory curves for IL-12p40 and TNF-α production by DCs in the presence of whole saliva, YM-3 filtrate, or standard PGE2, all tested in a dilution designed to contain comparable concentrations of PGE2. Accordingly, the curves were superimposable, indicating that similar levels of inhibition were attained regardless of the preparation. We thus concluded that PGE2 most likely accounts for most, if not all, inhibition of IL-12p40 (Fig. 6,A) and TNF-α (Fig. 6 B) observed with whole saliva. Finally, the YM-3 retentate, which includes molecules with molecular mass greater than 3000 Da and did not contain any detectable PGE2, consistently had no inhibitory effect on IL-12p40 and TNF-α production (data not shown).

FIGURE 6.

PGE2 accounts for the inhibitory effect of I. scapularis saliva on IL-12p40 and TNF-α production by LPS-stimulated CD11c+ DCs. A concentration-response inhibitory curve on LPS-induced IL-12p40 (A) and TNF-α (B) production by CD11c+ cells was performed using commercial PGE2 and compared with those achieved by YM-3-filtered and whole saliva with known amounts of PGE2.

FIGURE 6.

PGE2 accounts for the inhibitory effect of I. scapularis saliva on IL-12p40 and TNF-α production by LPS-stimulated CD11c+ DCs. A concentration-response inhibitory curve on LPS-induced IL-12p40 (A) and TNF-α (B) production by CD11c+ cells was performed using commercial PGE2 and compared with those achieved by YM-3-filtered and whole saliva with known amounts of PGE2.

Close modal

To further investigate the effects of saliva and PGE2 in DC maturation, bone marrow DCs were stimulated with LPS in the presence of medium (positive control), whole saliva, YM-3 filtrate, or PGE2. Subsequently, the expression of costimulatory molecules was analyzed by flow cytometry. Overnight incubation with LPS increased the surface expression of CD40, CD80, and CD86 in DCs (Fig. 7,A). Preincubation with saliva or YM-3 filtrate at 1/200 dilution (both containing ∼10 nM PGE2; Fig. 7,B) slightly inhibited LPS-induced expression of CD40; however, no effects could be demonstrated for CD80 or CD86 (Fig. 7,A). Notably, the same profile was observed with 10 nM standard PGE2 (Fig. 7 A). When higher concentrations of PGE2 (100 nM and 1 μM) were tested, CD80 or CD86 expression remained unchanged, but strong inhibition of CD40 expression in DCs was observed (data not shown). These findings suggest that PGE2 present in the saliva or YM-3 filtrate (1/200) dilution slightly suppresses LPS-induced CD40 expression by DCs.

FIGURE 7.

I. scapularis saliva and YM-3 filtrate marginally inhibit LPS-induced CD40, but do not affect CD80 and CD86 or MHC class II expression. Four million bone marrow-derived DCs were preincubated with medium, saliva (1/200), YM-3 filtrate (1/200), or PGE2 (10 nM) for 30 min prior to an overnight incubation in the presence of LPS (100 ng/ml). Cells were stained with fluorochrome-labeled Abs specific for CD11c, CD40, CD80, CD86, and MHC class II, and analyzed by flow cytometry. The data shown were gated for live CD11c+ cells (A). PGE2 content in the medium of each group was estimated by ELISA in the beginning of the incubation (B). Levels of IL-12p70 (C) and TNF-α (D) in the culture supernatant were estimated by ELISA at the end of the incubation period. ∗, p < 0.05 vs LPS-stimulated group.

FIGURE 7.

I. scapularis saliva and YM-3 filtrate marginally inhibit LPS-induced CD40, but do not affect CD80 and CD86 or MHC class II expression. Four million bone marrow-derived DCs were preincubated with medium, saliva (1/200), YM-3 filtrate (1/200), or PGE2 (10 nM) for 30 min prior to an overnight incubation in the presence of LPS (100 ng/ml). Cells were stained with fluorochrome-labeled Abs specific for CD11c, CD40, CD80, CD86, and MHC class II, and analyzed by flow cytometry. The data shown were gated for live CD11c+ cells (A). PGE2 content in the medium of each group was estimated by ELISA in the beginning of the incubation (B). Levels of IL-12p70 (C) and TNF-α (D) in the culture supernatant were estimated by ELISA at the end of the incubation period. ∗, p < 0.05 vs LPS-stimulated group.

Close modal

The DCs used in this assay constitutively presented high expression levels of MHC class II molecules, and LPS only marginally affected its expression. This pattern remained the same in the presence of saliva, YM-3 filtrate, or PGE2 (Fig. 7,A). To confirm that the concentration of PGE2 in our preparation, as quantified by ELISA (∼10 nM; Fig. 7,B), was pharmacologically active, the levels of IL-12 and TNF-α were measured in the culture supernatant of DCs stimulated by LPS. As expected, similar inhibition of both cytokines was observed in the presence of saliva, YM-3 filtrate, or PGE2 (Fig. 7, C and D).

DCs are the major cell type specialized in Ag presentation and induction of adaptive immune responses. We next investigated whether I. scapularis saliva influences the ability of DCs to activate CD4+ T cells in an Ag-specific manner and affects IL-2 production, a marker of T cell proliferation. Fig. 8 shows that DCs incubated in the presence of medium or LPS, but without OVA, did not induce proliferation (Fig. 8,A) or IL-2 (Fig. 8,B) production by CD4+ T cells from B10.11 mice. In contrast, DCs loaded with OVA in the presence of LPS induced Ag-specific proliferation and IL-2 production by CD4+ T cells (Fig. 8). More importantly, these responses were significantly inhibited by saliva (1/200), YM-3 filtrate (1/200), or 10 nM PGE2 (Fig. 8). Accordingly, our results support the concept that PGE2 accounts for the DC-immunomodulatory activity found in I. scapularis saliva in vitro.

FIGURE 8.

I. scapularis saliva and YM-3 filtrate decrease OVA-specific proliferation (A) and IL-2 production (B) by CD4+ T cells. Bone marrow DCs were preincubated with saliva (1/200), YM-3 filtrate (1/200), or PGE2 (10 nM) for 30 min prior to an overnight incubation with OVA (100 μg/ml) plus LPS (100 ng/ml). Cells were washed and 25,000 DCs were cocultured with 100,000 purified CD4+ T cells from DO11.10 mice for 72 h. Alamar Blue was added in the culture in the last 48-h incubation, and proliferation was assessed, as described in Materials and Methods. IL-2 production was determined in the culture supernatant by ELISA. ∗, p < 0.05 vs medium/LPS + OVA group.

FIGURE 8.

I. scapularis saliva and YM-3 filtrate decrease OVA-specific proliferation (A) and IL-2 production (B) by CD4+ T cells. Bone marrow DCs were preincubated with saliva (1/200), YM-3 filtrate (1/200), or PGE2 (10 nM) for 30 min prior to an overnight incubation with OVA (100 μg/ml) plus LPS (100 ng/ml). Cells were washed and 25,000 DCs were cocultured with 100,000 purified CD4+ T cells from DO11.10 mice for 72 h. Alamar Blue was added in the culture in the last 48-h incubation, and proliferation was assessed, as described in Materials and Methods. IL-2 production was determined in the culture supernatant by ELISA. ∗, p < 0.05 vs medium/LPS + OVA group.

Close modal

Tick modulation of the host’s innate and acquired immune response is recognized as a factor in the transmission of tick-borne diseases, such as Lyme borreliosis, babesiosis, and anaplasmosis (28, 29, 30). It has been suggested that I. scapularis saliva plays a role in infection, according to experimental model of guinea pig infestation with Borrelia burgdorferi-infected ticks (31). In fact, tick saliva contains molecules that prevent complement activation (32) and T cell proliferation (13, 15, 33), and that polarize T cell responses to a Th2 profile (34). Tick saliva also modulates cytokine production by epidermal cells (35) and alters expression of adhesion molecules by skin-derived endothelial cells (36). More recently, a study demonstrated that saliva from R. sanguineus inhibits differentiation, maturation, and cytokine synthesis of bone marrow-derived DCs (20). Despite the critical role of immunomodulators in tick-host interaction, the molecular cloning and identification of most of these molecules have not been reported.

In the experiments described in this study, we have further studied the properties of I. scapularis saliva on DC maturation and function. Accordingly, we demonstrated for the first time that I. scapularis saliva down-modulates IL-12 and TNF-α as well as up-regulates IL-10 production by DCs stimulated with TLR ligands (Figs. 1 and 2). These findings are particularly important because both TNF-α and IL-12 are major products of maturing DCs and contribute to inflammation and to adaptive immune response, whereas IL-10 has an anti-inflammatory activity (3, 37). Furthermore, using a number of purification steps involving microcon filtration (cutoff 3 kDa), molecular sieving, and reversed-phase HPLC chromatographies, we have unambiguously identified, by mass spectrometry, PGE2 as the molecule present in the active salivary fraction (Figs. 4 and 5). Notably, superimposable inhibitory curves for inhibition of cytokine production by DCs were observed with whole saliva, YM-3 filtrate, and the corresponding concentration of PGE2 (Fig. 6). It was concluded that PGE2 accounts for most, if not all, DC-inhibitory activity on cytokine production found with I. scapularis saliva in vitro.

The finding that PGE2 is responsible for the inhibition of IL-12/TNF-α produced by LPS-stimulated DCs has been previously reported (27, 38) and has several implications in our understanding of tick-feeding behavior and vector-host interactions. PGE2 is known to modulate inflammatory response and the subsequent activation of the adaptive immune system (39, 40). Of note, these processes are interdependent and display an important cross-talk that is essential for normal homeostasis. For example, inflammatory cytokines (e.g., TNF-α) produced by DCs and macrophages induce the changes required for DC maturation and migration from the periphery to the lymph nodes. The presence of inflammatory cytokines also leads to up-regulation of adhesion molecule by the endothelium (e.g., E-selectins), and these molecules contribute to the recruitment of monocytes and other cell types to inflamed tissue (3).

Tick saliva contains pharmacological (μM range) amounts of PGE2 (9, 41, 42, 43). Therefore, it is plausible to suggest that blockade of DC-mediated cytokine production by this prostanoid may contribute to anti-inflammation and immunosuppression in vivo. This assumption is supported by the fact that inhibition of cytokine production by DCs (Fig. 6) or macrophages (44) was attained at remarkably low doses of PGE2. Finally, saliva increases DC production of IL-10, an anti-inflammatory cytokine whose expression is modulated by PGE2 (27). IL-10 also serves as a potent mechanism for limiting the maturation of DCs and their capacity to initiate Th1 response (1). Because maturation and differentiation of Th1 T cells are particularly dependent on IL-12 and TNF-α (1, 3), cytokines whose production was dramatically inhibited in our assays, it is plausible to hypothesize that saliva down-regulates inflammation and impairs Th1 responses.

Subsequent to activation by a given stimulus, DCs undergo a maturation process in which expression of the costimulatory molecules and cytokines necessary to activate and differentiate naive T cells is up-regulated. To examine the effects of saliva in the maturation process of DCs, we tested its effects in the expression levels of CD40, CD80, CD86, and MHC class II and in the proliferation of CD4+ T cells. Our results demonstrate that saliva or YM-3 filtrate (both containing ∼10 nM PGE2) produced marginal inhibition of CD40 expression on one hand (Fig. 7,A), but a significant attenuation of T cell proliferation and IL-2 production in contrast (Fig. 8). Of note, these findings were replicated with standard PGE2 at similar concentrations. In other words, the effects observed with saliva in DC maturation are most likely due to its PGE2 content. It is important to recognize that high concentrations of PGE2 completely inhibited the expression of CD40 (data not shown). Whether such concentration of PGE2 is achievable in vivo is not known, and it may also differ according to the stage of tick development (e.g., nymphs vs adults) and/or the time of feeding (e.g., hours vs days) (45). Nevertheless, our data support the view that I. scapularis PGE2 is the major in vitro inhibitor of maturation and function of DCs. It may operate alone or in combination with other molecules with immunomodulatory/anti-inflammatory function that remains to be identified in I. scapularis saliva.

The notion that salivary PGE2 affects DC function is particularly relevant because these cells are resident in the skin, and are probably one of the first cells to interact with salivary components at the tick attachment site. In this context, evidence for saliva-DC interaction comes from studies in which epidermal cell population containing Langerhans cells (the immature DC population of skin) was incubated in vitro with tick saliva. These cells, loaded with salivary Ags, were able to stimulate proliferation of T lymphocytes obtained from the lymph node of bite-sensitized tick-resistant guinea pigs (46). This indicates that DCs are presumably capable of priming an immune response in vivo during tick infestation. That assumption is supported by an earlier study that identified the presence of Ags from ticks’ salivary glands associated with Langerhans cells (47). Another study showed that during primary infestations with D. andersoni, there is a decrease in the number of these cells around the sites of tick attachment. The authors have concluded that Langerhans cells migrate, probably to lymph nodes, after contact with components from saliva (48). In addition, murine splenic DCs or Langerhans cell-enriched epidermal cells that have been pulsed with live spirochetes mediate the production of anti-B. burgdorferi Abs in vitro (49). Finally, B. burgdorferi components are recognized by TLRs present in DCs (50). These results are consistent with the concept that DCs are active components in the immune response to tick saliva and potentially modulate pathogen transmission.

Therefore, PGE2 can be added to the increasing list of molecules characterized in I. scapularis saliva that modulate the immune system. As diagrammatically shown in Fig. 9, the putative and actual roles of these molecules on inflammation and adaptive immunity include inhibition of neutrophil accumulation (11), blockade of macrophage and T lymphocyte activation (51, 52), decrease in Ag presentation by DCs (40), and attenuation of IL-2 production by T lymphocytes (13, 14, 15). Therefore, inhibition of immune cell function by the tick saliva mixture provides further insights into the mechanism by which ticks successfully feed for extended periods of time. It also helps to explain how ticks regulate subsequent activation of acquired immune response to saliva components, tick mouthparts, and possibly, to the pathogens present in saliva.

FIGURE 9.

Immunomodulators identified in I. scapularis saliva or salivary gland extract: putative and described functions. Pleiotropic PGE2 effects include inhibition of DC cytokine production (2738 ) (Fig. 6), Ag presentation (40 ) (Fig. 8), macrophage (51 ), and T lymphocyte activation (52 ). Sialostatin L, which affects neutrophil migration (11 ), is an inhibitor of cathepsins L and S that are involved in Ag processing, presentation, and consequently in T cell proliferation (53 ). Salp15 was described as an inhibitor of T cell activation (13 ) through binding to the CD4 TCR (14 ). IL-2-binding protein decreases IL-2 availability affecting T cell proliferation (15 ).

FIGURE 9.

Immunomodulators identified in I. scapularis saliva or salivary gland extract: putative and described functions. Pleiotropic PGE2 effects include inhibition of DC cytokine production (2738 ) (Fig. 6), Ag presentation (40 ) (Fig. 8), macrophage (51 ), and T lymphocyte activation (52 ). Sialostatin L, which affects neutrophil migration (11 ), is an inhibitor of cathepsins L and S that are involved in Ag processing, presentation, and consequently in T cell proliferation (53 ). Salp15 was described as an inhibitor of T cell activation (13 ) through binding to the CD4 TCR (14 ). IL-2-binding protein decreases IL-2 availability affecting T cell proliferation (15 ).

Close modal

We thank Drs. Thomas E. Wellems, Robert W. Gwadz, Kathryn C. Zoon, and Alan Sher (National Institute of Allergy and Infectious Diseases/National Institutes of Health) for encouragement and support.

The authors have no financial conflict of interest.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1

This work was supported by funding from the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, and from National Institutes of Health Grant R01 AI37230 (to T.N.M.). It is contribution number 5078 of the Rhode Island Agricultural Experiment Station (to T.N.M.). This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract NO1-CO-12400 (to T.D.V.).

5

Abbreviations used in this paper: DC, dendritic cell; LTQ-FTICR, linear ion trap-Fourier transform ion cyclotron resonance mass spectrometer; MS, mass spectrometry; PGN, peptidoglycan; RPLC, reversed-phase liquid chromatography.

1
Banchereau, J., R. M. Steinman.
1998
. Dendritic cells and the control of immunity.
Nature
392
:
245
-252.
2
Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, P. Ricciardi-Castagnoli.
1997
. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures.
J. Exp. Med.
185
:
317
-328.
3
Iwasaki, A..
2007
. Mucosal dendritic cells.
Annu. Rev. Immunol.
25
:
381
-418.
4
Ribeiro, J. M., I. M. Francischetti.
2003
. Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives.
Annu. Rev. Entomol.
48
:
73
-88.
5
Francischetti, I. M., J. G. Valenzuela, J. F. Andersen, T. N. Mather, J. M. Ribeiro.
2002
. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.
Blood
99
:
3602
-3612.
6
Narasimhan, S., R. A. Koski, B. Beaulieu, J. F. Anderson, N. Ramamoorthi, F. Kantor, M. Cappello, E. Fikrig.
2002
. A novel family of anticoagulants from the saliva of Ixodes scapularis.
Insect Mol. Biol.
11
:
641
-650.
7
Ribeiro, J. M., G. T. Makoul, D. R. Robinson.
1988
. Ixodes dammini: evidence for salivary prostacyclin secretion.
J. Parasitol.
74
:
1068
-1069.
8
Francischetti, I. M., T. N. Mather, J. M. Ribeiro.
2005
. Tick saliva is a potent inhibitor of endothelial cell proliferation and angiogenesis.
Thromb. Haemostasis
94
:
167
-174.
9
Ribeiro, J. M., G. T. Makoul, J. Levine, D. R. Robinson, A. Spielman.
1985
. Antihemostatic, antiinflammatory, and immunosuppressive properties of the saliva of a tick, Ixodes dammini.
J. Exp. Med.
161
:
332
-344.
10
Fikrig, E., S. W. Barthold, F. S. Kantor, R. A. Flavell.
1990
. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.
Science
250
:
553
-556.
11
Kotsyfakis, M., A. Sá-Nunes, I. M. Francischetti, T. N. Mather, J. F. Andersen, J. M. Ribeiro.
2006
. Antiinflammatory and immunosuppressive activity of sialostatin L, a salivary cystatin from the tick Ixodes scapularis.
J. Biol. Chem.
281
:
26298
-26307.
12
Ribeiro, J. M., J. J. Weis, S. R. Telford, III.
1990
. Saliva of the tick Ixodes dammini inhibits neutrophil function.
Exp. Parasitol.
70
:
382
-388.
13
Anguita, J., N. Ramamoorthi, J. W. Hovius, S. Das, V. Thomas, R. Persinski, D. Conze, P. W. Askenase, M. Rincon, F. S. Kantor, E. Fikrig.
2002
. Salp15, an Ixodes scapularis salivary protein, inhibits CD4+ T cell activation.
Immunity
16
:
849
-859.
14
Garg, R., I. J. Juncadella, N. Ramamoorthi, Ashish, S. K. Ananthanarayanan, V. Tomas, M. Rincón, J. K. Krueger, E. Fikrig, C. M. Yengo, and J. Anguita. 2006. Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15. J. Immunol. 177: 6579–6583.
15
Gillespie, R. D., M. C. Dolan, J. Piesman, R. G. Titus.
2001
. Identification of an IL-2 binding protein in the saliva of the Lyme disease vector tick, Ixodes scapularis.
J. Immunol.
166
:
4319
-4326.
16
Ramachandra, R. N., S. K. Wikel.
1992
. Modulation of host-immune responses by ticks (Acari: Ixodidae): effect of salivary gland extracts on host macrophages and lymphocyte cytokine production.
J. Med. Entomol.
29
:
818
-826.
17
Zeidner, N., M. L. Mbow, M. Dolan, R. Massung, E. Baca, J. Piesman.
1997
. Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice.
Infect. Immun.
65
:
3100
-3106.
18
Schoeler, G. B., S. A. Manweiler, S. K. Wikel.
1999
. Ixodes scapularis: effects of repeated infestations with pathogen-free nymphs on macrophage and T-lymphocyte cytokine responses of BALB/c and C3H/HeN mice.
Exp. Parasitol.
92
:
239
-248.
19
Ferreira, B. R., J. S. Silva.
1998
. Saliva of Rhipicephalus sanguineus tick impairs T cell proliferation and IFN-γ-induced macrophage microbicidal activity.
Vet. Immunol. Immunopharmacol.
64
:
279
-293.
20
Cavassani, K. A., J. C. Aliberti, A. R. V. Dias, J. S. Silva, B. R. Ferreira.
2005
. Tick saliva inhibits differentiation, maturation and function of murine bone-marrow-derived dendritic cells.
Immunology
114
:
235
-245.
21
Tatchell, R. J..
1967
. A modified method for obtaining tick oral secretion.
J. Parasitol.
53
:
1106
-1107.
22
Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, R. M. Steinman.
1992
. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
J. Exp. Med.
176
:
1693
-1702.
23
Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, G. Schuler.
1999
. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.
J. Immunol. Methods
223
:
77
-92.
24
Bafica, A., C. A. Scanga, C. G. Feng, C. Leifer, A. Cheever, A. Sher.
2005
. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.
J. Exp. Med.
202
:
1715
-1724.
25
Ahmed, S. A., R. M. Gogal, Jr, J. E. Walsh.
1994
. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay.
J. Immunol. Methods
170
:
211
-224.
26
Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, et al
2000
. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.
Immunity
13
:
715
-725.
27
Harizi, H., M. Juzan, V. Pitard, J. F. Moreau, N. Gualde.
2002
. Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions.
J. Immunol.
168
:
2255
-2263.
28
Barbour, A. G..
1998
. Fall and rise of Lyme disease and other Ixodes tick-borne infections in North America and Europe.
Br. Med. Bull.
54
:
647
-658.
29
Schwan, T. G., J. Piesman.
2002
. Vector interactions and molecular adaptations of Lyme disease and relapsing fever spirochetes associated with transmission by ticks.
Emerg. Infect. Dis.
8
:
115
-121.
30
Hill, C. A., S. K. Wikel.
2005
. The Ixodes scapularis Genome Project: an opportunity for advancing tick research.
Trends Parasitol.
21
:
151
-153.
31
Nazario, S., S. Das, A. M. de Silva, K. Deponte, N. Marcantonio, J. F. Anderson, D. Fish, E. Fikrig, F. S. Kantor.
1998
. Prevention of Borrelia burgdorferi transmission in guinea pigs by tick immunity.
Am. J. Trop. Med. Hyg.
58
:
780
-785.
32
Valenzuela, J. G., R. Charlab, T. N. Mather, J. M. Ribeiro.
2000
. Purification, cloning, and expression of a novel salivary anticomplement protein from the tick, Ixodes scapularis.
J. Biol. Chem.
275
:
18717
-18723.
33
Schoeler, G. B., D. K. Bergman, S. A. Manweiler, S. K. Wikel.
2000
. Influence of soluble proteins from the salivary glands of ixodid ticks on the in vitro proliferative responses of lymphocytes from BALB/c and C3H/HeN mice.
Ann. Trop. Med. Parasitol.
94
:
507
-518.
34
Schoeler, G. B., S. A. Manweiler, S. K. Wikel.
2000
. Cytokine responses of C3H/HeN mice infested with Ixodes scapularis or Ixodes pacificus nymphs.
Parasite Immunol.
22
:
31
-40.
35
Pechova, J., J. Kopecky, J. Salat.
2004
. Effect of tick salivary gland extract on the cytokine production by mouse epidermal cells.
Folia Parasitol.
51
:
367
-372.
36
Maxwell, S. S., T. A. Stoklased, Y. Dash, K. R. Macaluso, S. K. Wikel.
2005
. Tick modulation of the in vitro expression of adhesion molecules by skin-derived endothelial cells.
Ann. Trop. Med. Parasitol.
99
:
661
-672.
37
Kapsenberg, M..
2003
. Dendritic cell control of pathogen-driven T-cell polarization.
Nat. Rev. Immunol.
3
:
984
-993.
38
Vassiliou, E., H. Jing, D. Ganea.
2003
. Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells.
Cell. Immunol.
223
:
120
-132.
39
Bowman, A. S., J. W. Dillwith, J. R. Sauer.
1996
. Tick salivary prostaglandins: presence, origin and significance.
Parasitol. Today
12
:
388
-396.
40
Harris, S. G., J. Padilla, L. Koumas, D. Ray, R. P. Phipps.
2002
. Prostaglandins as modulators of immunity.
Trends Immunol.
23
:
144
-150.
41
Ribeiro, J. M., P. M. Evans, J. L. MacSwain, J. Sauer.
1992
. Amblyomma americanum: characterization of salivary prostaglandins E2 and F2 α by RP-HPLC/bioassay and gas chromatography-mass spectrometry.
Exp. Parasitol.
74
:
112
-116.
42
Inokuma, H., D. H. Kemp, P. Willadsen.
1994
. Comparison of prostaglandin E2 (PGE2) in salivary gland of Boophilus microplus, Haemaphysalis longicornis and Ixodes holocyclus, and quantification of PGE2 in saliva, hemolymph, ovary and gut of B. microplus.
J. Vet. Med. Sci.
56
:
1217
-1218.
43
Urioste, S., L. R. Hall, S. R. Telford, III, R. G. Titus.
1994
. Saliva of the Lyme disease vector, Ixodes dammini, blocks cells activation by a nonprostaglandin E2-dependent mechanism.
J. Exp. Med.
180
:
1077
-1085.
44
Nataraj, C., D. W. Thomas, S. L. Tilley, M. T. Nguyen, R. Mannon, B. H. Koller, T. M. Coffman.
2001
. Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse.
J. Clin. Invest.
108
:
1229
-1235.
45
Ribeiro, J. M., F. Alarcon-Chaidez, I. M. Francischetti, B. J. Mans, T. N. Mather, J. G. Valenzuela, S. K. Wikel.
2006
. An annotated catalog of salivary gland transcripts from Ixodes scapularis ticks.
Insect Biochem. Mol. Biol.
36
:
111
-129.
46
Nithiuthai, S., J. R. Allen.
1985
. Langerhans cells present tick antigens to lymph node cells from tick-sensitized guinea-pigs.
Immunology
55
:
157
-163.
47
Allen, J. R., H. M. Khalil, S. K. Wikel.
1979
. Langerhans cells trap tick salivary gland antigens in tick-resistant guinea pigs.
J. Immunol.
122
:
563
-565.
48
Nithiuthai, S., J. R. Allen.
1984
. Significant changes in epidermal Langerhans cells of guinea-pigs infested with ticks (Dermacentor andersoni).
Immunology
51
:
133
-141.
49
Mbow, M. L., N. Zeidner, N. Panella, R. G. Titus, J. Piesman.
1997
. Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes.
Infect. Immun.
65
:
3386
-3390.
50
Singh, S. K., H. J. Girschick.
2006
. Toll-like receptors in Borrelia burgdorferi-induced inflammation.
Clin. Microbiol. Infect.
12
:
705
-717.
51
Strassmann, G., V. Patil-Koota, F. Finkelman, M. Fong, T. Kambayashi.
1994
. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.
J. Exp. Med.
180
:
2365
-2370.
52
Chouaib, S., R. J. Robb, K. Welte, B. DuPont.
1987
. Analysis of prostaglandin E2 effect on T lymphocyte activation: abrogation of prostaglandin E2 inhibitory effect by the tumor promoter 12.0 tetradecanoylphorbol-13 acetate.
J. Clin. Invest.
80
:
333
-340.
53
Hsieh, C. S., P. deRoos, K. Honey, C. Beers, A. Y. Rudensky.
2002
. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation.
J. Immunol.
168
:
2618
-2625.